Evaluation of Clinical and Ultrasonographic Parameters in Psoriatic Arthritis Patients Treated with Adalimumab: A Retrospective Study

Table 1

Patients demographics and disease characteristics at baseline.

Number of patients	40
Male/female	21/19
Age, (mean ± SD)	51.5 ± 10.3
Duration of disease
Psoriasis (mean ± SD)	22.2 ± 11.5
Psoriatic arthritis (mean ± SD)	10.7 ± 7.7
PASI (mean ± SD)	9.2 ± 10.8
Pain VAS (mean ± SD)	65 ± 21.3
DAS 28 (mean ± SD)	4.6 ± 1.5
ESR (mean ± SD)	34.7 ± 21.6
CRP (mean ± SD)	20.8 ± 16.4
Age of onset (mean ± SD)
Psoriasis (mean ± SD)	29.3 ± 16.5
Psoriatic arthritis (mean ± SD)	40.8 ± 12.2
Previous methotrexate treatment	31 (77.5%)
Previous ciclosporin treatment	35 (87.5%)
Previous pUVA-UVB treatment	14 (35%)
Previous leflunomide treatment	17 (42.5%)
Previous sulphasalazine treatment	12 (30%)